The societal costs of intracerebral hemorrhage in Spain

European Journal of Neurology

Volumn 14, Issue 5, 2007, Pages 556-562

  Navarrete Navarro, P ^b   Hart, W M ^c   Lopez Bastida, J ^d   Christensen, M C ^a  

^a NOVO NORDISK A S   (Denmark)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^c EcoStat Consulting UK   (United Kingdom)

^d Canary Islands Health Service   (Spain)

Author keywords

Direct costs; Economics; Indirect costs; Intracerebral hemorrhage; Societal costs; Spain

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; MORBIDITY; OUTPATIENT CARE; PATIENT CARE; PRIORITY JOURNAL; PRODUCTIVITY; PUBLICATION; QUESTIONNAIRE; REHABILITATION CARE; RETROSPECTIVE STUDY; SPAIN; STANDARD; SURVIVAL;

AGED; AMBULATORY CARE; CEREBRAL HEMORRHAGE; COHORT STUDIES; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; REHABILITATION; RETROSPECTIVE STUDIES; SPAIN; SURVIVAL RATE; WORKERS' COMPENSATION;

EID: 34247173506     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2007.01756.x     Document Type: Article

References (37)

1. Navarrete P, Garcia A, Murillo F, et al. La patología cerebrovascular aguda en las Areas de Cuidados Críticos y Urgencias de Andalucía. Análisis clínicos-epidemiológicos y de práctica médica. Proyecto EVASCAN. Medicina Intensiva 2000; 24: 257-263.
2. Broderick J, Brott T, Tomsick T, Miller R, Huster G. Intracerebral hemorrhage is more than twice as common as subarachnoid hemorrhage. Journal of Neurosurgery 1993; 78: 188-191.
3. Sanidad y Consumo (Ministry of Health and Consumer Affairs), Madrid, 2005. Health Statistics - Mortality 2003: Stroke, http://www.msc.es (accessed 22 March, 2007).
4. Geffner-Sclarsky D. Hospital care for stroke patients in the Valencian Region using the basic minimum data set from the International Classification of Diseases, 9th revision, clinical modification. Revista de Neurologia 2006; 42: 584-590.
5. Truelsen T, Ekman M, Boysen G. Cost of stroke in Europe. European Journal of Neurology 2005; 12(Suppl. 1): 78-84.
6. Dewey HM, Thrift AG, Mihalopoulos C, et al. Lifetime cost of stroke subtypes in Australia: findings from the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke 2003; 34: 2502-2507.
7. Taylor TN, Davis PH, Torner JC, Holmes J, Meyer JW, Jacobson MF. Lifetime cost of stroke in the United States. Stroke 1996; 27: 1459-1466.
8. Beguiristain JM, Mar J, Arrazola A. The cost of cerebrovascular accident. Revista de Neurologia 2005; 40: 406-411.
9. Smith D, Gravelle H. The Practice of Discounting Economic Evaluations of Health Care Interventions. CHE Technical Paper Series 11. York: University of York, 2000.
10. Perez-Sempere A. Cerebrovascular morbidity in Spain: incidence and prevalence. Revista de Neurologia 1999; 29: 879-881.
11. Jover-Saenz A, Porcel-Perez JM, Vives-Soto M, Rubio-Caballero M. Epidemiology of acute cerebrovascular disease in Lleida from 1996 to 1997. Predictive factors of mortality at short and medium term. Revista de Neurologia 1999; 28: 941-948.
12. Lopez-Pousa S, Vilalta J, Llinas J. Incidence of cerebrovascular disease in Spain: a study in a rural area of Girona. Revista de Neurologia 1995; 23: 1074-1080.
13. Caicoya M, Rodríguez T, Lasheras C, et al. Stroke incidence in Asturias 1990-1991. Revista de Neurologia 1996; 24: 806-811.
14. Abadal LT, Puig T, Balaguer Vintro I. Incidence, mortality and risk factors for stroke in the Manresa study: 28 years of follow-up. Revista Española de Cardiología 2000; 53: 15-20.
15. Navarrete-Navarro P, Rivera-Fernandez R, Lopez-Mutuberria MT, et al. Outcome prediction in terms of functional disability and mortality at 1 year among ICU-admitted severe stroke patients: a prospective epidemiological study in the south of the European Union (EVASCAN Project, Andalusia, Spain). Intensive Care Medicine 2003; 29: 1237-1244.
16. Instituto Nacional de Estadística (National Istitute of Statistics), Madrid, 2005. INEbase - Demography and Population. http://www.ine.es (accessed 22 March, 2007).
17. Arboix A, Comes E, Garcia-Eroles L, et al. Site of bleeding and early outcome in primary intracerebral hemorrhage. Acta Neurologica Scandinavica 2002; 105: 282-288.
18. Lopez-Bastida J, Serrano-Aguilar P, Perestelo-Perez L, Oliva-Moreno J. Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain. Neurology 2006; 67: 2186-2191.
19. Gisbert R, Brosa M. Costes Sanitarios. Barcelona: Centro de Estudios en Economía de la Salud y de Política Social (SOIKOS), 2005.
20. Vademecum Internacional. Vademecum Online: el localizador de medicamentos. Available at: http://www.vademecum.es/ (accessed 22 March, 2007).
21. Instituto Nacional de Estadística (National Istitute of Statistics), Madrid, 2005. INEbase-Encuesta Trimestral de Coste Laboral (ETCL). http://www.ine.es (accessed 22 March, 2007).
22. Marti Fabregas J, Belvis R, Guardia E, Cocho D, Marti-Vilalta JL. Relationship between transcranial doppler and CT data in acute intracerebral hemorrhage. American Journal of Neuroradiology 2005; 26: 113-118.
23. Cocho D, Borrell M, Marti-Fabregas J, et al. Pretreatment hemostatic markers of symptomatic intracerebral hemorrhage in patients treated with tissue plasminogen activator. Stroke 2006; 37: 996-999.
24. Mayer S, Brun N, Broderick J, et al. Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage. Stroke 2005; 36: 74-79.
25. Geffner-Sclarsky D. Hospital care for stroke patients in the Valencian Region using the basic minimum data set from the International Classification of Diseases, 9th revision, clinical modification. Revista de Neurologia 2006; 42: 584-590.
26. Maulden SA, Gassaway J, Horn SD, Smout RJ, DeJong G. Timing of initiation of rehabilitation after stroke. Archives of Physical Medicine and Rehabilitation 2005; 86 (12 Suppl. 2): S34.
27. von Koch L, de Pedro-Cuesta J, Kostulas V, Almazán J, Widén Holmqvist L. Randomized controlled trial of rehabilitation at home after stroke: one-year follow-up of patient outcome, resource use and cost. Cerebrovascular Diseases 2001; 12: 131-138.
28. Kaste M, Fogelholm R, Rissanen A. Economic burden of stroke and the evaluation of new therapies. Public Health 1998; 112: 103-112.
29. Persson U, Silverberg R, Lindaren B, et al. Direct costs of stroke for a Swedish population. International Journal of Technology Assessment in Health Care 1990; 6: 125-137.
30. Youman P, Wilson K, Harraf F, Kalra L. The economic burden of stroke in the United Kingdom. Pharmacoeconomics 2003; 21(Suppl.): 43-50.
31. Bergman L, van der Meulen JH, Limburg M, Habbema JD. Costs of medical care after first-ever stroke in the Netherlands. Stroke 1995; 26: 1830-1836.
32. Porsdal V, Boysen G. Direct costs during the first year after intracerebral hemorrhage. European Journal of Neurology 1999; 6: 449-454.
33. Weimar C, Weber C, Wagner M, et al. Management patterns and health care use after intracerebral hemorrhage. A cost-of-illness study from a societal perspective in Germany. Cerebrovascular Diseases 2003; 15: 29-36.
34. Carod-Artal FJ, Egido-Navarro JA, Gonzalez-Guitierrez JL, Varela de Seijas E. Coste directo de la enfermedad cerebrovascular en el primer año de seguimiento. Revista de Neurologia 1999; 28: 1123-1130.
35. BOE nú m. 128. LEY 16/2003, de 28 de mayo, de cohesión y calidad del Sistema Nacional de Salud. Jueves 29 de mayo de, 2003, pp. 20567-20588.
36. Ministerio de Sanidad y Consumo. Informe Anual del Sistema Nacional de Salud Español 2004. Madrid: Ministerio de Sanidad y Consumo, 2006. (http://www.msc.es/organización/sns/informeAnualSNS/home.htm) (accessed 22 March, 2007).
37. McCullagh E, Brigstocke G, Donaldson N, Kalra L. Determinants of caregiving burden and quality of life in caregivers of stroke patients. Stroke 2005; 36: 2181-2186.